佐力药业12月29日获融资买入5180.81万元，融资余额5.84亿元

Group 1 - On December 29, Zhaoli Pharmaceutical experienced a decline of 2.21% with a transaction volume of 269 million yuan. The financing buy amount for the day was 51.81 million yuan, while the financing repayment was 28.78 million yuan, resulting in a net financing buy of 23.03 million yuan. As of December 29, the total financing and securities lending balance was 586 million yuan [1] - The financing balance of Zhaoli Pharmaceutical on December 29 was 584 million yuan, accounting for 5.08% of the circulating market value, which is above the 70th percentile level over the past year, indicating a high position [1] - On the same day, Zhaoli Pharmaceutical repaid 800 shares in securities lending and sold 18,300 shares, with a selling amount of 300,100 yuan. The remaining securities lending volume was 133,700 shares, with a balance of 2.19 million yuan, exceeding the 90th percentile level over the past year, also indicating a high position [1] Group 2 - As of September 30, Zhaoli Pharmaceutical had 41,400 shareholders, an increase of 7.31% compared to the previous period. The average circulating shares per person decreased by 6.82% to 14,562 shares [2] - For the period from January to September 2025, Zhaoli Pharmaceutical achieved an operating income of 2.28 billion yuan, representing a year-on-year growth of 11.48%. The net profit attributable to the parent company was 510 million yuan, with a year-on-year increase of 21.00% [2] - Since its A-share listing, Zhaoli Pharmaceutical has distributed a total of 1.442 billion yuan in dividends, with 942 million yuan distributed in the last three years [3]